One tumor with a RET/PTC1 rearrangement and another with RET/PTC3 were identified in the pediatric population (15%).     ///    "Additionally, we examined the rate of RAS point mutations with real-time polymerase chain reaction and rearrangements of RET/PTC1 and RET/PTC3 in the pediatric group with fluorescence in situ hybridization. "